THRX

Theravance, Inc. Press Releases

$29.03
*  
0.03
0.1%
Get THRX Alerts
*Delayed - data as of Jul. 10, 2014 13:45 ET  -  Find a broker to begin trading THRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    THRX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Anoro(R) Ellipta(R) (Umeclidinium/Vilanterol) Gains Approval in Japan for the Treatment of COPD
7/7/2014 8:00:00 AM - Market Wire

Theravance, Inc. Appoints Theodore J. Witek, Jr. as Senior Vice President, Corporate Partnerships, Clinical and Medical Affairs
7/2/2014 4:05:00 PM - Market Wire

GSK and Theravance Announce Submission to US Regulatory Authorities for Fluticasone Furoate/Vilanterol in Asthma
6/30/2014 8:04:00 AM - Market Wire

Analyst Scanner on Health Care Sector Equities -- Research on Vical, VCA Inc., TherapeuticsMD, and Theravance
6/16/2014 8:00:00 AM - PR Newswire

Theravance, Inc. Appoints George B. Abercrombie as Senior Vice President, Corporate Partnerships, Commercial
6/12/2014 5:15:00 PM - Market Wire

GSK and Theravance Announce Positive Data From Two Studies Evaluating the Efficacy and Safety of Incruse(TM) Ellipta(R) When Added to Relvar(R)/Breo(R) Ellipta(R) in Patients With COPD
6/11/2014 7:40:00 AM - Market Wire

Theravance, Inc. and Theravance Biopharma, Inc. Announce Completion of Separation of Late-Stage Partnered Respiratory Assets From Biopharmaceutical Operations
6/2/2014 8:05:00 PM - Market Wire

Theravance to Present at the Jefferies 2014 Healthcare Conference
5/21/2014 4:05:00 PM - Market Wire

Theravance, Inc. Announces Effectiveness of Form 10 Registration Statement of Theravance Biopharma, Inc.
5/15/2014 4:45:00 PM - Market Wire

Theravance to Webcast 2014 Annual Meeting of Stockholders on May 22, 2014
5/15/2014 4:05:00 PM - Market Wire

Technical Coverage on Biotech Stocks -- Research on Athersys, Lexicon Pharma, Biogen Idec, and Theravance
5/12/2014 12:30:00 PM - PR Newswire

Theravance Study Results Confirm in vitro Potency of VIBATIV(R) (telavancin) and Efficacy in Patients With Complicated Skin and Skin Structure Infections Including MRSA
5/9/2014 6:01:00 PM - Market Wire

Anoro(R) (Umeclidinium/Vilanterol) Gains Marketing Authorisation in Europe for the Treatment of COPD
5/8/2014 11:11:00 AM - Market Wire

Theravance, Inc. Announces May 15 Record Date and June 2 Share Issue Date for Separation Into Two Companies via a Stock Dividend
5/6/2014 4:05:00 PM - Market Wire

Theravance to Present New Data Confirming in vitro Potency of VIBATIV(R) (telavancin) and Efficacy in Patients With Complicated Skin and Skin Structure Infections Including MRSA at 2014 ECCMID Conference
5/1/2014 8:00:00 AM - Market Wire

Theravance Announces Positive Results From a Phase 2 Study of TD-9855 in Patients With Fibromyalgia
4/30/2014 4:05:00 PM - Market Wire

Theravance to Present at the Bank of America Merrill Lynch 2014 Health Care Conference
4/29/2014 4:05:00 PM - Market Wire

Anoro™ Ellipta® now available in the US for treatment of COPD
4/28/2014 8:54:00 AM - PR Newswire

Anoro(TM) Ellipta(R) Now Available in the US for Treatment of COPD
4/28/2014 8:00:00 AM - Market Wire

GSK and Theravance Announce Phase III Study of Fluticasone Furoate/Vilanterol in COPD Commenced to Support Potential Future Filing in Japan
4/22/2014 8:45:00 AM - Market Wire

Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
4/21/2014 4:30:00 AM - Market Wire

Theravance to Report First Quarter 2014 Financial Results on May 6, 2014
4/15/2014 4:05:00 PM - Market Wire